This invention is in the field of identifying patients having rheumatic heart disease (RHD) associated with Streptococcus pyogenes (Group A Streptococcus; GAS) infection and identifying patients at risk of developing RHD associated with GAS infection. The invention also provides methods and compositions for preventing and treating RHD associated with GAS infection.
申请公布号
CA2778333(A1)
申请公布日期
2011.04.28
申请号
CA20102778333
申请日期
2010.10.20
申请人
NOVARTIS AG
发明人
MARGARIT Y ROS, IMMACULADA;VALERIO, REGUZZI;AHMED, SOHAIL;GRANDI, GUIDO;BARTOLINI, ERIKA